Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fusion Proteins, bcr-abl | 60 | 2014 | 434 | 6.240 |
Why?
|
fms-Like Tyrosine Kinase 3 | 38 | 2021 | 491 | 6.150 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 44 | 2021 | 689 | 4.540 |
Why?
|
Leukemia, Myeloid, Acute | 74 | 2022 | 3524 | 3.960 |
Why?
|
Staurosporine | 24 | 2020 | 251 | 3.230 |
Why?
|
Pyrimidines | 50 | 2016 | 2943 | 3.180 |
Why?
|
Protein Kinase Inhibitors | 39 | 2020 | 5535 | 2.920 |
Why?
|
Leukemia, Myeloid | 37 | 2020 | 707 | 2.740 |
Why?
|
Colony-Stimulating Factors | 49 | 1990 | 221 | 2.730 |
Why?
|
Protein-Tyrosine Kinases | 62 | 2014 | 2455 | 2.690 |
Why?
|
Piperazines | 41 | 2016 | 2488 | 2.400 |
Why?
|
Proto-Oncogene Proteins | 54 | 2018 | 4554 | 2.240 |
Why?
|
Interleukin-3 | 35 | 2005 | 444 | 1.830 |
Why?
|
Antineoplastic Agents | 51 | 2022 | 13695 | 1.810 |
Why?
|
Leukemia | 21 | 2016 | 1511 | 1.730 |
Why?
|
Hematopoietic Stem Cells | 65 | 2005 | 3390 | 1.680 |
Why?
|
Drug Resistance, Neoplasm | 32 | 2019 | 5173 | 1.540 |
Why?
|
Cell Transformation, Neoplastic | 35 | 2011 | 2943 | 1.400 |
Why?
|
Growth Substances | 31 | 2002 | 784 | 1.390 |
Why?
|
Thiazoles | 8 | 2013 | 1483 | 1.320 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 46 | 1999 | 903 | 1.300 |
Why?
|
Point Mutation | 13 | 2014 | 1624 | 1.290 |
Why?
|
Mutant Proteins | 6 | 2019 | 500 | 1.270 |
Why?
|
Proto-Oncogene Proteins c-cbl | 12 | 2020 | 119 | 1.270 |
Why?
|
Receptor Protein-Tyrosine Kinases | 16 | 2013 | 1660 | 1.220 |
Why?
|
Tyrosine | 32 | 2011 | 1462 | 1.200 |
Why?
|
Signal Transduction | 77 | 2020 | 23406 | 1.200 |
Why?
|
Nuclear Proteins | 24 | 2015 | 5857 | 1.100 |
Why?
|
Enzyme Inhibitors | 24 | 2016 | 3799 | 1.070 |
Why?
|
Hematologic Neoplasms | 6 | 2022 | 1832 | 1.070 |
Why?
|
Benzamides | 36 | 2013 | 1379 | 1.030 |
Why?
|
Mutation | 46 | 2021 | 29786 | 1.020 |
Why?
|
Phosphorylation | 71 | 2021 | 8437 | 0.960 |
Why?
|
Genes, abl | 11 | 2006 | 72 | 0.950 |
Why?
|
Janus Kinase 2 | 19 | 2021 | 528 | 0.930 |
Why?
|
Adaptor Proteins, Signal Transducing | 16 | 2002 | 2918 | 0.930 |
Why?
|
Trans-Activators | 21 | 2021 | 2926 | 0.910 |
Why?
|
Cell Line, Tumor | 42 | 2024 | 16692 | 0.870 |
Why?
|
Milk Proteins | 6 | 2005 | 169 | 0.840 |
Why?
|
Cell Line | 89 | 2014 | 16000 | 0.840 |
Why?
|
Transcription Factors | 23 | 2022 | 12209 | 0.830 |
Why?
|
Phosphoproteins | 21 | 2003 | 2441 | 0.820 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 11 | 1999 | 110 | 0.810 |
Why?
|
Granulocytes | 28 | 2018 | 548 | 0.810 |
Why?
|
Receptor, Notch2 | 3 | 2014 | 89 | 0.800 |
Why?
|
Tumor Cells, Cultured | 51 | 2021 | 6314 | 0.800 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 6 | 2012 | 379 | 0.800 |
Why?
|
Bone Marrow Cells | 34 | 2013 | 2513 | 0.770 |
Why?
|
Leukemia, Experimental | 8 | 2016 | 246 | 0.770 |
Why?
|
Proto-Oncogene Proteins c-kit | 12 | 2019 | 776 | 0.760 |
Why?
|
Hematopoiesis | 26 | 2002 | 2073 | 0.760 |
Why?
|
Proto-Oncogene Proteins c-abl | 7 | 2010 | 146 | 0.750 |
Why?
|
Cell Cycle | 29 | 2014 | 2968 | 0.740 |
Why?
|
Cell Division | 51 | 2005 | 4569 | 0.730 |
Why?
|
Alternative Splicing | 4 | 2014 | 1117 | 0.730 |
Why?
|
Hematopoietic Cell Growth Factors | 9 | 1999 | 102 | 0.710 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2020 | 449 | 0.700 |
Why?
|
Mice | 117 | 2024 | 81202 | 0.700 |
Why?
|
Animals | 166 | 2024 | 168770 | 0.690 |
Why?
|
Therapies, Investigational | 1 | 2020 | 112 | 0.690 |
Why?
|
Drug Repositioning | 2 | 2022 | 230 | 0.680 |
Why?
|
Ubiquitin-Protein Ligases | 9 | 2002 | 1862 | 0.660 |
Why?
|
Small Molecule Libraries | 4 | 2021 | 720 | 0.650 |
Why?
|
Antiviral Agents | 3 | 2022 | 2987 | 0.640 |
Why?
|
Monocytes | 28 | 1992 | 2596 | 0.640 |
Why?
|
Gene Expression Regulation, Neoplastic | 17 | 2022 | 8432 | 0.610 |
Why?
|
Phosphatidylinositol 3-Kinases | 16 | 2024 | 2938 | 0.600 |
Why?
|
Drug Synergism | 12 | 2020 | 1797 | 0.590 |
Why?
|
Cytoskeletal Proteins | 12 | 2003 | 1364 | 0.590 |
Why?
|
Stromal Cells | 8 | 2013 | 1355 | 0.580 |
Why?
|
Cell Proliferation | 27 | 2021 | 10484 | 0.570 |
Why?
|
Histones | 2 | 2022 | 2599 | 0.560 |
Why?
|
Receptors, Cell Surface | 14 | 2003 | 2866 | 0.540 |
Why?
|
Antigens, Surface | 31 | 1991 | 1663 | 0.540 |
Why?
|
Oncogene Proteins, Fusion | 9 | 2021 | 1581 | 0.540 |
Why?
|
src Homology Domains | 9 | 2003 | 364 | 0.530 |
Why?
|
DNA-Binding Proteins | 19 | 2018 | 9647 | 0.530 |
Why?
|
Apoptosis | 32 | 2024 | 9726 | 0.520 |
Why?
|
Humans | 341 | 2024 | 744376 | 0.510 |
Why?
|
Phosphotyrosine | 15 | 2009 | 457 | 0.500 |
Why?
|
Isoquinolines | 3 | 2016 | 366 | 0.500 |
Why?
|
Recombinant Fusion Proteins | 18 | 2007 | 3773 | 0.500 |
Why?
|
Xenograft Model Antitumor Assays | 14 | 2021 | 3556 | 0.490 |
Why?
|
Transfection | 33 | 2005 | 5895 | 0.490 |
Why?
|
Benzothiazoles | 5 | 2020 | 248 | 0.490 |
Why?
|
Receptors, Notch | 10 | 2009 | 739 | 0.490 |
Why?
|
Cell Cycle Proteins | 6 | 2014 | 3465 | 0.480 |
Why?
|
Genes, ras | 2 | 2014 | 690 | 0.480 |
Why?
|
Up-Regulation | 8 | 2021 | 4222 | 0.470 |
Why?
|
Tetradecanoylphorbol Acetate | 15 | 1992 | 821 | 0.470 |
Why?
|
Drug Screening Assays, Antitumor | 9 | 2019 | 730 | 0.470 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 12 | 2021 | 11525 | 0.460 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2016 | 381 | 0.460 |
Why?
|
Bone Marrow | 43 | 2004 | 2948 | 0.460 |
Why?
|
Membrane Proteins | 14 | 2015 | 7882 | 0.460 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 | 2006 | 1520 | 0.450 |
Why?
|
Cell Survival | 21 | 2017 | 5882 | 0.450 |
Why?
|
Protein Tyrosine Phosphatases | 10 | 2001 | 473 | 0.450 |
Why?
|
Enzyme Activation | 25 | 2013 | 3702 | 0.440 |
Why?
|
STAT5 Transcription Factor | 13 | 2012 | 259 | 0.440 |
Why?
|
Cyclins | 7 | 2006 | 603 | 0.430 |
Why?
|
Cell Movement | 14 | 2010 | 5218 | 0.430 |
Why?
|
RNA Precursors | 1 | 2013 | 209 | 0.420 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3135 | 0.420 |
Why?
|
Protein Kinases | 11 | 2008 | 1640 | 0.420 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2010 | 215 | 0.420 |
Why?
|
Oncogenes | 9 | 2013 | 1265 | 0.420 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3242 | 0.410 |
Why?
|
Receptor, IGF Type 1 | 1 | 2014 | 390 | 0.410 |
Why?
|
RNA, Messenger | 30 | 2015 | 13035 | 0.410 |
Why?
|
Receptor, Notch1 | 4 | 2018 | 502 | 0.410 |
Why?
|
Neoplasm Proteins | 11 | 2016 | 3706 | 0.410 |
Why?
|
Phenylurea Compounds | 4 | 2020 | 528 | 0.400 |
Why?
|
GTP Phosphohydrolases | 1 | 2015 | 508 | 0.400 |
Why?
|
Protein Structure, Tertiary | 17 | 2012 | 3848 | 0.400 |
Why?
|
Protein Kinase C | 5 | 2008 | 1227 | 0.390 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 4 | 1997 | 437 | 0.390 |
Why?
|
Mutation, Missense | 6 | 2010 | 2566 | 0.390 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2014 | 1692 | 0.390 |
Why?
|
Cell Line, Transformed | 12 | 2003 | 898 | 0.380 |
Why?
|
Myeloproliferative Disorders | 8 | 2021 | 606 | 0.380 |
Why?
|
Amino Acid Substitution | 7 | 2010 | 1793 | 0.380 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2020 | 2949 | 0.380 |
Why?
|
Carcinoma, Mucoepidermoid | 3 | 2021 | 88 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-akt | 10 | 2016 | 2504 | 0.370 |
Why?
|
Stem Cell Factor | 10 | 1999 | 219 | 0.370 |
Why?
|
Insect Proteins | 2 | 2002 | 258 | 0.370 |
Why?
|
Mice, Nude | 12 | 2016 | 3689 | 0.360 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2010 | 98 | 0.350 |
Why?
|
Cytarabine | 10 | 2000 | 692 | 0.350 |
Why?
|
Receptors, Erythropoietin | 4 | 2008 | 147 | 0.350 |
Why?
|
Recombinant Proteins | 32 | 2005 | 6621 | 0.350 |
Why?
|
DNA, Complementary | 5 | 2004 | 2050 | 0.340 |
Why?
|
Carbanilides | 1 | 2008 | 17 | 0.330 |
Why?
|
src-Family Kinases | 3 | 2010 | 551 | 0.330 |
Why?
|
Granulocyte Colony-Stimulating Factor | 11 | 1994 | 648 | 0.330 |
Why?
|
RNA Splicing | 1 | 2013 | 908 | 0.330 |
Why?
|
Phosphoric Monoester Hydrolases | 3 | 2000 | 431 | 0.330 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2024 | 1434 | 0.330 |
Why?
|
Leukemia, Lymphoid | 13 | 2005 | 315 | 0.330 |
Why?
|
Cell Adhesion Molecules | 12 | 2002 | 1602 | 0.330 |
Why?
|
Benzimidazoles | 3 | 2020 | 850 | 0.330 |
Why?
|
Biological Products | 1 | 2017 | 860 | 0.330 |
Why?
|
Multiple Myeloma | 7 | 2022 | 5181 | 0.320 |
Why?
|
Drug Design | 4 | 2013 | 1076 | 0.320 |
Why?
|
B-Lymphocytes | 18 | 2014 | 4666 | 0.320 |
Why?
|
Gene Expression Regulation, Leukemic | 5 | 2014 | 651 | 0.310 |
Why?
|
Cell Adhesion | 15 | 2011 | 3144 | 0.310 |
Why?
|
Neoplastic Stem Cells | 12 | 1997 | 1376 | 0.310 |
Why?
|
Thrombocythemia, Essential | 2 | 2006 | 105 | 0.310 |
Why?
|
Dose-Response Relationship, Drug | 22 | 2017 | 10943 | 0.310 |
Why?
|
Reactive Oxygen Species | 7 | 2010 | 2076 | 0.300 |
Why?
|
Thrombopoietin | 4 | 1999 | 225 | 0.300 |
Why?
|
Transcriptional Activation | 6 | 2014 | 1783 | 0.300 |
Why?
|
Carrier Proteins | 8 | 2007 | 5023 | 0.300 |
Why?
|
Polycythemia Vera | 2 | 2006 | 164 | 0.300 |
Why?
|
Cell Physiological Phenomena | 1 | 2008 | 154 | 0.300 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2021 | 5445 | 0.290 |
Why?
|
Precipitin Tests | 15 | 2004 | 829 | 0.290 |
Why?
|
G1 Phase | 7 | 2006 | 415 | 0.290 |
Why?
|
Receptors, CXCR4 | 1 | 2011 | 727 | 0.290 |
Why?
|
Molecular Sequence Data | 27 | 2010 | 18111 | 0.290 |
Why?
|
Mutagenesis | 3 | 2009 | 1264 | 0.290 |
Why?
|
Aniline Compounds | 3 | 2021 | 986 | 0.280 |
Why?
|
Receptors, Immunologic | 9 | 1995 | 1423 | 0.280 |
Why?
|
Erythropoietin | 6 | 2008 | 726 | 0.270 |
Why?
|
Lymphoid Tissue | 2 | 2007 | 455 | 0.270 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2007 | 166 | 0.270 |
Why?
|
Cytokines | 12 | 2016 | 7323 | 0.270 |
Why?
|
Proto-Oncogenes | 6 | 2003 | 321 | 0.270 |
Why?
|
Interferon-gamma | 14 | 1996 | 3207 | 0.270 |
Why?
|
Biomimetic Materials | 1 | 2007 | 179 | 0.260 |
Why?
|
Transcription, Genetic | 18 | 2010 | 7722 | 0.260 |
Why?
|
Pyrazines | 3 | 2021 | 1230 | 0.260 |
Why?
|
MAP Kinase Kinase Kinases | 2 | 2016 | 261 | 0.260 |
Why?
|
T-Lymphocytes | 19 | 2007 | 10183 | 0.260 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3020 | 0.250 |
Why?
|
Cadherins | 1 | 2009 | 907 | 0.250 |
Why?
|
Adaptor Proteins, Vesicular Transport | 3 | 1996 | 315 | 0.250 |
Why?
|
DNA Mutational Analysis | 9 | 2010 | 4185 | 0.250 |
Why?
|
Pyrimidinones | 3 | 2021 | 371 | 0.250 |
Why?
|
Proteins | 12 | 2002 | 6100 | 0.250 |
Why?
|
Cells, Cultured | 33 | 2020 | 19233 | 0.250 |
Why?
|
Interleukin-1 | 7 | 1992 | 1263 | 0.250 |
Why?
|
CDC2 Protein Kinase | 3 | 2018 | 220 | 0.240 |
Why?
|
Down-Regulation | 10 | 2011 | 3001 | 0.240 |
Why?
|
Amino Acid Sequence | 19 | 2016 | 13814 | 0.240 |
Why?
|
Antibodies, Monoclonal | 44 | 1997 | 9274 | 0.240 |
Why?
|
Blast Crisis | 3 | 2004 | 103 | 0.240 |
Why?
|
Megakaryocytes | 8 | 2000 | 545 | 0.240 |
Why?
|
Inhibitory Concentration 50 | 4 | 2015 | 459 | 0.230 |
Why?
|
Lymphoma | 5 | 2016 | 1877 | 0.230 |
Why?
|
Structure-Activity Relationship | 13 | 2017 | 3130 | 0.230 |
Why?
|
Immunoblotting | 9 | 2010 | 1683 | 0.230 |
Why?
|
Pandemics | 2 | 2020 | 8386 | 0.220 |
Why?
|
Philadelphia Chromosome | 6 | 2001 | 112 | 0.220 |
Why?
|
Tandem Repeat Sequences | 1 | 2004 | 185 | 0.220 |
Why?
|
Genes | 7 | 2004 | 1893 | 0.220 |
Why?
|
Janus Kinases | 3 | 2013 | 244 | 0.220 |
Why?
|
Drosophila Proteins | 3 | 2003 | 1703 | 0.220 |
Why?
|
Protease Inhibitors | 3 | 2020 | 791 | 0.220 |
Why?
|
Antigens, Differentiation | 8 | 1994 | 927 | 0.220 |
Why?
|
Quinolines | 1 | 2008 | 732 | 0.220 |
Why?
|
Models, Biological | 13 | 2011 | 9584 | 0.220 |
Why?
|
Kinetics | 19 | 1999 | 6476 | 0.210 |
Why?
|
Pyrazoles | 4 | 2021 | 1972 | 0.210 |
Why?
|
Base Sequence | 18 | 2014 | 12797 | 0.210 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2004 | 789 | 0.210 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 2002 | 76 | 0.210 |
Why?
|
Molecular Structure | 5 | 2017 | 1899 | 0.210 |
Why?
|
Preoptic Area | 3 | 1998 | 146 | 0.210 |
Why?
|
Blotting, Northern | 13 | 2003 | 1581 | 0.210 |
Why?
|
Oligopeptides | 2 | 2007 | 1189 | 0.210 |
Why?
|
Phorbols | 4 | 1985 | 43 | 0.200 |
Why?
|
Patient Compliance | 1 | 2012 | 2685 | 0.200 |
Why?
|
Gene Expression Regulation | 17 | 2005 | 12073 | 0.200 |
Why?
|
Receptors, Interleukin-3 | 2 | 1999 | 30 | 0.200 |
Why?
|
Imidazoles | 1 | 2008 | 1206 | 0.200 |
Why?
|
Drug Resistance | 5 | 2021 | 1608 | 0.200 |
Why?
|
Piperidines | 2 | 2020 | 1602 | 0.200 |
Why?
|
Drug Discovery | 4 | 2014 | 1058 | 0.190 |
Why?
|
S Phase | 5 | 2006 | 423 | 0.190 |
Why?
|
Protein Interaction Mapping | 1 | 2005 | 627 | 0.190 |
Why?
|
Mitochondrial Proteins | 1 | 2007 | 994 | 0.190 |
Why?
|
K562 Cells | 9 | 2011 | 635 | 0.190 |
Why?
|
Neutrophils | 11 | 1994 | 3721 | 0.190 |
Why?
|
Models, Molecular | 12 | 2016 | 5451 | 0.190 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 5 | 1996 | 48 | 0.190 |
Why?
|
Antigens, Neoplasm | 18 | 1991 | 1988 | 0.190 |
Why?
|
Acute Disease | 14 | 2004 | 7147 | 0.190 |
Why?
|
Pyrroles | 2 | 2019 | 1146 | 0.190 |
Why?
|
Flow Cytometry | 15 | 2015 | 5974 | 0.180 |
Why?
|
Guanine Nucleotide-Releasing Factor 2 | 1 | 1999 | 5 | 0.180 |
Why?
|
Phosphatidylinositols | 1 | 2001 | 291 | 0.180 |
Why?
|
Colony-Forming Units Assay | 12 | 1992 | 356 | 0.180 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2006 | 643 | 0.180 |
Why?
|
Mice, Inbred NOD | 4 | 2017 | 1879 | 0.180 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 3647 | 0.180 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 182 | 0.180 |
Why?
|
Cell Differentiation | 31 | 2018 | 11486 | 0.180 |
Why?
|
Doxycycline | 4 | 2021 | 326 | 0.180 |
Why?
|
Cytoskeleton | 3 | 2003 | 1185 | 0.180 |
Why?
|
mRNA Cleavage and Polyadenylation Factors | 3 | 2005 | 98 | 0.180 |
Why?
|
Sequence Homology, Amino Acid | 6 | 2004 | 2839 | 0.180 |
Why?
|
Paxillin | 9 | 2003 | 86 | 0.180 |
Why?
|
Ambulatory Care | 1 | 2010 | 2708 | 0.170 |
Why?
|
Genes, Retinoblastoma | 4 | 1992 | 136 | 0.170 |
Why?
|
Talin | 2 | 1996 | 44 | 0.170 |
Why?
|
Oncogene Proteins v-abl | 2 | 2000 | 22 | 0.170 |
Why?
|
Vanadates | 6 | 2000 | 82 | 0.170 |
Why?
|
Protein Binding | 12 | 2005 | 9384 | 0.170 |
Why?
|
Antigens, CD | 10 | 2002 | 4026 | 0.170 |
Why?
|
Medication Adherence | 1 | 2010 | 2063 | 0.170 |
Why?
|
Health Resources | 2 | 2019 | 911 | 0.170 |
Why?
|
Methylation | 1 | 2022 | 1106 | 0.170 |
Why?
|
Quinazolines | 1 | 2005 | 1356 | 0.170 |
Why?
|
NF-kappa B | 3 | 2010 | 2499 | 0.160 |
Why?
|
Cell Separation | 14 | 2000 | 1751 | 0.160 |
Why?
|
Ubiquitination | 2 | 2020 | 1012 | 0.160 |
Why?
|
Salivary Gland Neoplasms | 2 | 2021 | 298 | 0.160 |
Why?
|
Half-Life | 3 | 2012 | 661 | 0.160 |
Why?
|
Chemokines, CXC | 1 | 1999 | 422 | 0.160 |
Why?
|
Escherichia coli Proteins | 1 | 2005 | 1050 | 0.160 |
Why?
|
Myeloid Progenitor Cells | 1 | 2018 | 111 | 0.160 |
Why?
|
Oncogene Proteins | 3 | 2002 | 749 | 0.160 |
Why?
|
Interleukin-2 | 9 | 1996 | 1904 | 0.160 |
Why?
|
Histocompatibility Antigens Class II | 4 | 1986 | 1475 | 0.160 |
Why?
|
Receptors, Interleukin | 1 | 1999 | 245 | 0.160 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2024 | 1378 | 0.160 |
Why?
|
Gene Expression Profiling | 5 | 2016 | 9445 | 0.150 |
Why?
|
Hypothalamus, Anterior | 1 | 1997 | 14 | 0.150 |
Why?
|
Streptomyces | 1 | 2017 | 89 | 0.150 |
Why?
|
Mice, SCID | 4 | 2015 | 2717 | 0.150 |
Why?
|
Cell Growth Processes | 2 | 2010 | 399 | 0.150 |
Why?
|
Triazines | 1 | 2019 | 315 | 0.150 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2021 | 1596 | 0.150 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 9 | 1991 | 222 | 0.150 |
Why?
|
Alleles | 4 | 2019 | 6933 | 0.150 |
Why?
|
Health Care Costs | 1 | 2010 | 3209 | 0.150 |
Why?
|
Binding Sites | 10 | 2012 | 6111 | 0.150 |
Why?
|
Sirolimus | 5 | 2005 | 1565 | 0.140 |
Why?
|
Class III Phosphatidylinositol 3-Kinases | 1 | 2016 | 18 | 0.140 |
Why?
|
Simian virus 40 | 5 | 1980 | 297 | 0.140 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2004 | 2015 | 0.140 |
Why?
|
Protein Processing, Post-Translational | 8 | 2002 | 1988 | 0.140 |
Why?
|
Chemotaxis | 1 | 1999 | 607 | 0.140 |
Why?
|
Neoplasm Transplantation | 5 | 2016 | 2086 | 0.140 |
Why?
|
Pharmaceutical Preparations | 1 | 2005 | 1070 | 0.140 |
Why?
|
Hematopoietic System | 1 | 1996 | 109 | 0.140 |
Why?
|
Retroviridae | 7 | 2005 | 914 | 0.140 |
Why?
|
Cell Communication | 6 | 2013 | 1621 | 0.140 |
Why?
|
Receptors, Granulocyte Colony-Stimulating Factor | 2 | 1994 | 21 | 0.140 |
Why?
|
Leukemia, B-Cell | 1 | 2016 | 86 | 0.140 |
Why?
|
Body Temperature Regulation | 1 | 1997 | 252 | 0.130 |
Why?
|
Blood Cells | 3 | 1996 | 309 | 0.130 |
Why?
|
Gene Expression | 13 | 2015 | 7798 | 0.130 |
Why?
|
Burkitt Lymphoma | 2 | 2016 | 327 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-pim-1 | 2 | 2008 | 34 | 0.130 |
Why?
|
Ethers, Cyclic | 2 | 1992 | 33 | 0.130 |
Why?
|
Cyclin-Dependent Kinases | 2 | 1998 | 671 | 0.130 |
Why?
|
Receptors, Colony-Stimulating Factor | 6 | 1990 | 49 | 0.130 |
Why?
|
Microtubule-Associated Proteins | 1 | 2000 | 1085 | 0.130 |
Why?
|
Tissue Banks | 1 | 2016 | 184 | 0.130 |
Why?
|
Glycogen Synthase | 1 | 2015 | 62 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 3 | 2007 | 2850 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2014 | 648 | 0.130 |
Why?
|
Female | 53 | 2021 | 380200 | 0.130 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 6 | 2009 | 122 | 0.120 |
Why?
|
Blotting, Western | 11 | 2010 | 5181 | 0.120 |
Why?
|
Carcinoma, Small Cell | 5 | 2003 | 420 | 0.120 |
Why?
|
Receptors, Interleukin-2 | 4 | 1989 | 573 | 0.120 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 12262 | 0.120 |
Why?
|
Growth Inhibitors | 4 | 2005 | 385 | 0.120 |
Why?
|
Clone Cells | 10 | 1994 | 1692 | 0.120 |
Why?
|
Glycogen | 1 | 2015 | 259 | 0.120 |
Why?
|
RNA, Small Interfering | 4 | 2015 | 3505 | 0.120 |
Why?
|
Mice, Inbred BALB C | 8 | 2016 | 6387 | 0.120 |
Why?
|
Receptors, Cytokine | 3 | 2009 | 262 | 0.120 |
Why?
|
Gene Knockdown Techniques | 2 | 2021 | 1656 | 0.120 |
Why?
|
Antigens, Viral | 6 | 1982 | 1035 | 0.120 |
Why?
|
Molecular Targeted Therapy | 4 | 2016 | 2726 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-crk | 3 | 1999 | 13 | 0.120 |
Why?
|
Male | 52 | 2021 | 350118 | 0.120 |
Why?
|
Ligands | 7 | 2009 | 3282 | 0.120 |
Why?
|
3T3 Cells | 5 | 2000 | 1101 | 0.120 |
Why?
|
Protein Conformation | 5 | 2013 | 4010 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2006 | 323 | 0.120 |
Why?
|
Mutagenesis, Site-Directed | 4 | 2005 | 1723 | 0.120 |
Why?
|
Escherichia coli | 2 | 2005 | 4217 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-vav | 3 | 2002 | 95 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2009 | 1115 | 0.110 |
Why?
|
Cell Nucleus | 6 | 2010 | 2969 | 0.110 |
Why?
|
RNA Interference | 1 | 2022 | 2891 | 0.110 |
Why?
|
Retinoblastoma Protein | 5 | 2021 | 705 | 0.110 |
Why?
|
Phosphoprotein Phosphatases | 2 | 1992 | 338 | 0.110 |
Why?
|
Histiocytes | 2 | 1987 | 103 | 0.110 |
Why?
|
Time Factors | 20 | 2007 | 40077 | 0.110 |
Why?
|
Thiophenes | 1 | 2017 | 589 | 0.110 |
Why?
|
Repressor Proteins | 4 | 2007 | 3024 | 0.110 |
Why?
|
Hydrogen Peroxide | 3 | 2002 | 730 | 0.110 |
Why?
|
Hypereosinophilic Syndrome | 2 | 2003 | 93 | 0.110 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 222 | 0.110 |
Why?
|
Middle Aged | 39 | 2021 | 213388 | 0.110 |
Why?
|
Hydroxamic Acids | 3 | 2004 | 494 | 0.110 |
Why?
|
Rosette Formation | 9 | 1988 | 153 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 7 | 2004 | 1837 | 0.110 |
Why?
|
Lymphocyte Activation | 11 | 1997 | 5524 | 0.110 |
Why?
|
Gamma Rays | 2 | 2007 | 320 | 0.100 |
Why?
|
Fructose-Bisphosphatase | 1 | 2011 | 24 | 0.100 |
Why?
|
Preleukemia | 4 | 1986 | 35 | 0.100 |
Why?
|
Phosphofructokinase-2 | 1 | 2011 | 32 | 0.100 |
Why?
|
Translocation, Genetic | 6 | 2004 | 1420 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-raf | 5 | 1996 | 203 | 0.100 |
Why?
|
Adult | 42 | 2021 | 214056 | 0.100 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 610 | 0.100 |
Why?
|
Pimozide | 1 | 2011 | 21 | 0.100 |
Why?
|
Enzyme Stability | 1 | 2011 | 210 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2000 | 1903 | 0.100 |
Why?
|
Health Care Surveys | 1 | 2019 | 2453 | 0.100 |
Why?
|
Treatment Outcome | 5 | 2021 | 63115 | 0.100 |
Why?
|
Leukemia, Erythroblastic, Acute | 2 | 2006 | 189 | 0.100 |
Why?
|
Molecular Sequence Annotation | 1 | 2013 | 528 | 0.100 |
Why?
|
Drug Approval | 1 | 2017 | 742 | 0.100 |
Why?
|
Benzylamines | 1 | 2011 | 223 | 0.100 |
Why?
|
Comorbidity | 2 | 2019 | 10388 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2010 | 4424 | 0.090 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 6 | 2001 | 1801 | 0.090 |
Why?
|
Bone Marrow Transplantation | 8 | 2005 | 2765 | 0.090 |
Why?
|
Heterocyclic Compounds | 1 | 2011 | 249 | 0.090 |
Why?
|
Indazoles | 1 | 2012 | 290 | 0.090 |
Why?
|
STAT1 Transcription Factor | 3 | 1996 | 320 | 0.090 |
Why?
|
Pyridones | 2 | 2013 | 712 | 0.090 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2007 | 1157 | 0.090 |
Why?
|
Crystallography, X-Ray | 3 | 2016 | 2012 | 0.090 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2004 | 692 | 0.090 |
Why?
|
Serous Membrane | 1 | 1989 | 28 | 0.090 |
Why?
|
Coculture Techniques | 2 | 2011 | 1341 | 0.090 |
Why?
|
Adenosine Triphosphate | 2 | 2010 | 2027 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2001 | 1431 | 0.090 |
Why?
|
Superoxides | 3 | 1989 | 387 | 0.090 |
Why?
|
COS Cells | 2 | 2002 | 1161 | 0.090 |
Why?
|
Stem Cells | 5 | 1993 | 3567 | 0.090 |
Why?
|
Tumor Burden | 1 | 2015 | 1915 | 0.090 |
Why?
|
Recurrence | 3 | 2019 | 8340 | 0.090 |
Why?
|
I-kappa B Proteins | 1 | 2010 | 225 | 0.090 |
Why?
|
Threonine | 1 | 2010 | 279 | 0.090 |
Why?
|
In Situ Hybridization | 2 | 2004 | 1950 | 0.080 |
Why?
|
Lymphoma, B-Cell | 2 | 2014 | 931 | 0.080 |
Why?
|
Lymphocytes | 8 | 1996 | 2617 | 0.080 |
Why?
|
Prognosis | 11 | 2021 | 29060 | 0.080 |
Why?
|
Clinical Trials as Topic | 4 | 2009 | 7914 | 0.080 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 4 | 1997 | 234 | 0.080 |
Why?
|
Chimera | 2 | 2007 | 485 | 0.080 |
Why?
|
Survival Rate | 8 | 2015 | 12788 | 0.080 |
Why?
|
HL-60 Cells | 3 | 2018 | 365 | 0.080 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8642 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2004 | 1284 | 0.080 |
Why?
|
DNA, Neoplasm | 4 | 2004 | 1758 | 0.080 |
Why?
|
Aminoacridines | 2 | 1985 | 9 | 0.080 |
Why?
|
Sulfonamides | 2 | 2021 | 1940 | 0.080 |
Why?
|
Transcription Factor RelA | 1 | 2010 | 275 | 0.080 |
Why?
|
Hydroxyurea | 3 | 2000 | 289 | 0.080 |
Why?
|
Antigens, CD34 | 3 | 2001 | 659 | 0.080 |
Why?
|
Viral Proteins | 3 | 2002 | 1900 | 0.080 |
Why?
|
Cloning, Molecular | 5 | 2004 | 4320 | 0.080 |
Why?
|
Biological Factors | 1 | 1989 | 164 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2018 | 988 | 0.080 |
Why?
|
Isotope Labeling | 1 | 2009 | 406 | 0.080 |
Why?
|
Cyclin D2 | 3 | 2006 | 101 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2460 | 0.080 |
Why?
|
Sequence Alignment | 2 | 2004 | 2256 | 0.080 |
Why?
|
Integrins | 3 | 1997 | 846 | 0.080 |
Why?
|
Eye Neoplasms | 1 | 1990 | 312 | 0.080 |
Why?
|
Luminescent Measurements | 1 | 2010 | 405 | 0.080 |
Why?
|
Tumor Stem Cell Assay | 6 | 2002 | 118 | 0.080 |
Why?
|
Killer Cells, Natural | 3 | 1987 | 2133 | 0.080 |
Why?
|
Mediastinal Neoplasms | 2 | 1983 | 423 | 0.080 |
Why?
|
Aged | 25 | 2021 | 163284 | 0.080 |
Why?
|
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2007 | 33 | 0.070 |
Why?
|
Shc Signaling Adaptor Proteins | 3 | 1996 | 46 | 0.070 |
Why?
|
Retinoblastoma | 1 | 1990 | 317 | 0.070 |
Why?
|
Cycloheximide | 3 | 2000 | 347 | 0.070 |
Why?
|
Leukemia, Promyelocytic, Acute | 3 | 2003 | 236 | 0.070 |
Why?
|
Lymphokines | 4 | 2002 | 949 | 0.070 |
Why?
|
Vinculin | 2 | 1997 | 62 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 5 | 2008 | 2110 | 0.070 |
Why?
|
Radiation Chimera | 1 | 2007 | 223 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2014 | 2715 | 0.070 |
Why?
|
Genes, bcl-2 | 1 | 2007 | 122 | 0.070 |
Why?
|
Immunotoxins | 3 | 1999 | 179 | 0.070 |
Why?
|
Neoplasms, Experimental | 3 | 2021 | 1276 | 0.070 |
Why?
|
Gene Frequency | 1 | 2013 | 3587 | 0.070 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2021 | 539 | 0.070 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2007 | 180 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 4751 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2021 | 77459 | 0.070 |
Why?
|
Membrane Glycoproteins | 3 | 1997 | 3771 | 0.070 |
Why?
|
Plasmids | 4 | 2003 | 2308 | 0.070 |
Why?
|
Metabolomics | 1 | 2015 | 1485 | 0.070 |
Why?
|
Pyridines | 2 | 2012 | 2825 | 0.070 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 1989 | 436 | 0.070 |
Why?
|
Mice, Inbred C3H | 3 | 1997 | 964 | 0.070 |
Why?
|
Macromolecular Substances | 5 | 1996 | 1454 | 0.070 |
Why?
|
Alprostadil | 1 | 1986 | 89 | 0.070 |
Why?
|
Myogenic Regulatory Factors | 1 | 2006 | 106 | 0.070 |
Why?
|
Insurance Claim Review | 1 | 2010 | 720 | 0.070 |
Why?
|
Myeloid Cells | 1 | 2010 | 810 | 0.070 |
Why?
|
Protein Transport | 2 | 2002 | 1988 | 0.070 |
Why?
|
Culture Media | 6 | 1989 | 909 | 0.070 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2005 | 105 | 0.070 |
Why?
|
Leukocyte Count | 7 | 1995 | 1588 | 0.070 |
Why?
|
Polymerase Chain Reaction | 4 | 2000 | 6171 | 0.060 |
Why?
|
Promoter Regions, Genetic | 5 | 2010 | 5868 | 0.060 |
Why?
|
Bone Marrow Purging | 3 | 1999 | 109 | 0.060 |
Why?
|
RNA, Neoplasm | 5 | 1992 | 769 | 0.060 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 4 | 2002 | 182 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2000 | 640 | 0.060 |
Why?
|
Disease Models, Animal | 8 | 2015 | 18034 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2004 | 2649 | 0.060 |
Why?
|
Antibodies, Neoplasm | 2 | 1984 | 286 | 0.060 |
Why?
|
Mycoplasma | 1 | 2005 | 139 | 0.060 |
Why?
|
Nucleic Acid Hybridization | 5 | 1990 | 1375 | 0.060 |
Why?
|
Macrophage Colony-Stimulating Factor | 3 | 1989 | 193 | 0.060 |
Why?
|
Epothilones | 1 | 2004 | 44 | 0.060 |
Why?
|
Acetylation | 2 | 2004 | 1084 | 0.060 |
Why?
|
Interphase | 5 | 1989 | 226 | 0.060 |
Why?
|
Receptors, Antigen, B-Cell | 4 | 1997 | 548 | 0.060 |
Why?
|
Cyclin D3 | 2 | 1995 | 55 | 0.060 |
Why?
|
Gene Duplication | 1 | 2005 | 329 | 0.060 |
Why?
|
Karyotyping | 9 | 2003 | 1243 | 0.060 |
Why?
|
Blood Cell Count | 2 | 2004 | 403 | 0.060 |
Why?
|
Proteomics | 1 | 2017 | 3638 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2007 | 3617 | 0.060 |
Why?
|
Radiation Tolerance | 1 | 2007 | 486 | 0.060 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1996 | 708 | 0.060 |
Why?
|
HLA-DR Antigens | 6 | 1995 | 645 | 0.060 |
Why?
|
Sequence Deletion | 3 | 1998 | 1526 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 1999 | 4255 | 0.060 |
Why?
|
DNA Primers | 5 | 2006 | 2891 | 0.060 |
Why?
|
DNA Replication | 7 | 1992 | 1399 | 0.060 |
Why?
|
Mosaicism | 1 | 2007 | 441 | 0.060 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2004 | 185 | 0.060 |
Why?
|
Luciferases | 2 | 2003 | 733 | 0.060 |
Why?
|
Aminopeptidases | 1 | 2003 | 88 | 0.060 |
Why?
|
Chromosomes, Mammalian | 1 | 2004 | 151 | 0.060 |
Why?
|
Chromosome Aberrations | 6 | 1995 | 1813 | 0.060 |
Why?
|
Disease-Free Survival | 2 | 2013 | 6896 | 0.060 |
Why?
|
Artificial Gene Fusion | 1 | 2003 | 57 | 0.060 |
Why?
|
Membrane Potentials | 6 | 1997 | 1137 | 0.060 |
Why?
|
Glycoproteins | 2 | 1991 | 2266 | 0.060 |
Why?
|
Mesothelioma | 1 | 1989 | 818 | 0.060 |
Why?
|
Fever | 3 | 1998 | 1616 | 0.060 |
Why?
|
Thrombocytopenia | 3 | 1990 | 1178 | 0.060 |
Why?
|
Morpholines | 2 | 2010 | 571 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 6 | 2001 | 2916 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1213 | 0.050 |
Why?
|
Primary Myelofibrosis | 1 | 2005 | 215 | 0.050 |
Why?
|
Chromosome Mapping | 3 | 2004 | 4740 | 0.050 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 514 | 0.050 |
Why?
|
Models, Chemical | 1 | 2005 | 626 | 0.050 |
Why?
|
Epidermal Growth Factor | 1 | 2005 | 709 | 0.050 |
Why?
|
Oncogene Protein v-cbl | 1 | 2002 | 11 | 0.050 |
Why?
|
Ankyrins | 1 | 2002 | 128 | 0.050 |
Why?
|
Embryo, Mammalian | 2 | 2010 | 1701 | 0.050 |
Why?
|
Peptides | 5 | 2009 | 4410 | 0.050 |
Why?
|
Homeodomain Proteins | 2 | 2009 | 2418 | 0.050 |
Why?
|
Hydroquinones | 1 | 2002 | 36 | 0.050 |
Why?
|
Interleukin-6 | 5 | 2004 | 3203 | 0.050 |
Why?
|
Breast Neoplasms | 1 | 2009 | 20823 | 0.050 |
Why?
|
Microfilament Proteins | 2 | 1999 | 1152 | 0.050 |
Why?
|
Substrate Specificity | 2 | 2004 | 1802 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 4 | 1988 | 1369 | 0.050 |
Why?
|
Leucine | 1 | 2003 | 560 | 0.050 |
Why?
|
Okadaic Acid | 2 | 1992 | 67 | 0.050 |
Why?
|
Drug Evaluation | 3 | 1991 | 647 | 0.050 |
Why?
|
Animals, Genetically Modified | 1 | 2007 | 1549 | 0.050 |
Why?
|
Leupeptins | 1 | 2001 | 122 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2006 | 6489 | 0.050 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2003 | 367 | 0.050 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2003 | 417 | 0.050 |
Why?
|
Recombination, Genetic | 2 | 2005 | 1586 | 0.050 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2003 | 430 | 0.050 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3616 | 0.050 |
Why?
|
Growth Cones | 1 | 2002 | 117 | 0.050 |
Why?
|
Phenotype | 12 | 2016 | 16367 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2016 | 9957 | 0.050 |
Why?
|
GRB2 Adaptor Protein | 2 | 2002 | 103 | 0.050 |
Why?
|
Muscles | 2 | 2006 | 1614 | 0.050 |
Why?
|
Cyclic AMP | 1 | 2005 | 1472 | 0.050 |
Why?
|
Genes, fos | 2 | 1999 | 183 | 0.050 |
Why?
|
Introns | 1 | 2004 | 992 | 0.050 |
Why?
|
Asparagine | 1 | 2001 | 122 | 0.050 |
Why?
|
Enzyme Induction | 3 | 2002 | 475 | 0.050 |
Why?
|
Temperature | 5 | 1997 | 2204 | 0.050 |
Why?
|
Oncogene Fusion | 1 | 2021 | 99 | 0.050 |
Why?
|
Rotenone | 1 | 2000 | 43 | 0.050 |
Why?
|
Microscopy, Video | 2 | 2000 | 245 | 0.050 |
Why?
|
Chromones | 1 | 2000 | 154 | 0.050 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2000 | 192 | 0.050 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 1992 | 294 | 0.050 |
Why?
|
Adamantane | 1 | 2002 | 173 | 0.050 |
Why?
|
Macrophage-1 Antigen | 3 | 1991 | 290 | 0.050 |
Why?
|
L-Selectin | 5 | 1991 | 214 | 0.050 |
Why?
|
Multigene Family | 2 | 2002 | 1102 | 0.050 |
Why?
|
Anti-Bacterial Agents | 4 | 2004 | 7182 | 0.050 |
Why?
|
Zebrafish Proteins | 1 | 2007 | 1005 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 7 | 2010 | 2505 | 0.050 |
Why?
|
Crk-Associated Substrate Protein | 2 | 1997 | 41 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 3 | 2002 | 850 | 0.050 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2007 | 852 | 0.050 |
Why?
|
Retinoblastoma-Like Protein p130 | 2 | 1997 | 76 | 0.050 |
Why?
|
Primates | 1 | 1983 | 545 | 0.050 |
Why?
|
Cytochalasin D | 2 | 1999 | 92 | 0.050 |
Why?
|
Endothelium, Vascular | 3 | 1991 | 4458 | 0.040 |
Why?
|
Phthalazines | 1 | 2002 | 363 | 0.040 |
Why?
|
Phosphotransferases | 2 | 1993 | 308 | 0.040 |
Why?
|
Species Specificity | 2 | 2000 | 2478 | 0.040 |
Why?
|
Leukemia, Myeloid, Chronic-Phase | 1 | 2000 | 38 | 0.040 |
Why?
|
Genes, Insect | 1 | 2000 | 268 | 0.040 |
Why?
|
Forkhead Transcription Factors | 2 | 2004 | 1613 | 0.040 |
Why?
|
Thymidine | 3 | 1991 | 310 | 0.040 |
Why?
|
DNA Repair | 1 | 2009 | 2046 | 0.040 |
Why?
|
Radiation, Ionizing | 1 | 2000 | 258 | 0.040 |
Why?
|
Dexamethasone | 4 | 2004 | 1951 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 694 | 0.040 |
Why?
|
Receptors, Interleukin-5 | 1 | 1999 | 19 | 0.040 |
Why?
|
Thiocarbamates | 1 | 1999 | 31 | 0.040 |
Why?
|
Genes, Reporter | 2 | 2003 | 1547 | 0.040 |
Why?
|
Mercaptoethanol | 1 | 1999 | 64 | 0.040 |
Why?
|
Focal Adhesion Kinase 1 | 2 | 1999 | 120 | 0.040 |
Why?
|
Leukopoiesis | 1 | 1999 | 56 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2003 | 578 | 0.040 |
Why?
|
Gene Deletion | 1 | 2007 | 2751 | 0.040 |
Why?
|
Binding, Competitive | 2 | 1991 | 1157 | 0.040 |
Why?
|
Codon | 1 | 2001 | 611 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-fos | 2 | 1999 | 575 | 0.040 |
Why?
|
Calcium | 5 | 1989 | 5755 | 0.040 |
Why?
|
Adenosine Triphosphatases | 2 | 1982 | 839 | 0.040 |
Why?
|
Lipopolysaccharides | 4 | 1998 | 2216 | 0.040 |
Why?
|
Antibody Specificity | 4 | 1997 | 1095 | 0.040 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2000 | 1381 | 0.040 |
Why?
|
bcl-X Protein | 1 | 2000 | 411 | 0.040 |
Why?
|
Liver | 5 | 2010 | 7475 | 0.040 |
Why?
|
CDC2-CDC28 Kinases | 1 | 1998 | 113 | 0.040 |
Why?
|
Diphtheria Toxin | 1 | 1999 | 255 | 0.040 |
Why?
|
Cell Membrane | 3 | 1987 | 3749 | 0.040 |
Why?
|
Spodoptera | 2 | 1996 | 153 | 0.040 |
Why?
|
Hydrogen Bonding | 2 | 2012 | 291 | 0.040 |
Why?
|
Tolmetin | 1 | 1998 | 23 | 0.040 |
Why?
|
Macrophages | 8 | 1988 | 5660 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12356 | 0.040 |
Why?
|
Chromosome Deletion | 1 | 2003 | 1401 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2003 | 1677 | 0.040 |
Why?
|
Microscopy, Fluorescence | 2 | 2002 | 2700 | 0.040 |
Why?
|
Protein Biosynthesis | 2 | 2002 | 2126 | 0.040 |
Why?
|
Fibronectins | 2 | 1999 | 726 | 0.040 |
Why?
|
Leukocytes | 4 | 1991 | 2045 | 0.040 |
Why?
|
Bovine papillomavirus 1 | 1 | 1997 | 74 | 0.040 |
Why?
|
Exons | 1 | 2004 | 2439 | 0.040 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 1983 | 501 | 0.040 |
Why?
|
Rabbits | 3 | 1995 | 4894 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 705 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2010 | 14561 | 0.040 |
Why?
|
Genes, myc | 3 | 2000 | 399 | 0.040 |
Why?
|
Neprilysin | 3 | 1991 | 439 | 0.040 |
Why?
|
Acetylcysteine | 1 | 1999 | 271 | 0.040 |
Why?
|
Erythroblasts | 2 | 1988 | 150 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2021 | 57776 | 0.040 |
Why?
|
Pharmacogenetics | 1 | 2002 | 674 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 1999 | 537 | 0.040 |
Why?
|
Chemokine CXCL12 | 1 | 1999 | 465 | 0.040 |
Why?
|
RNA | 3 | 2000 | 2749 | 0.040 |
Why?
|
Antigen-Antibody Reactions | 4 | 1987 | 363 | 0.040 |
Why?
|
Lymphocytosis | 1 | 1978 | 119 | 0.040 |
Why?
|
Son of Sevenless Proteins | 1 | 1997 | 27 | 0.040 |
Why?
|
Nocodazole | 2 | 1999 | 97 | 0.040 |
Why?
|
Reticulocytes | 1 | 1978 | 290 | 0.040 |
Why?
|
Cytoplasm | 1 | 2002 | 1536 | 0.040 |
Why?
|
Receptors, Thrombopoietin | 2 | 1995 | 157 | 0.040 |
Why?
|
Erythroid Precursor Cells | 2 | 2002 | 218 | 0.040 |
Why?
|
Injections, Intraperitoneal | 1 | 1997 | 425 | 0.040 |
Why?
|
Pyrrolidines | 1 | 1999 | 342 | 0.040 |
Why?
|
Cyclin D1 | 2 | 2003 | 463 | 0.040 |
Why?
|
Neoplasms | 3 | 2013 | 21693 | 0.040 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 1996 | 86 | 0.040 |
Why?
|
STAT3 Transcription Factor | 2 | 2005 | 874 | 0.040 |
Why?
|
Chemical Precipitation | 1 | 1996 | 179 | 0.040 |
Why?
|
Microsomes, Liver | 1 | 2016 | 173 | 0.040 |
Why?
|
Epitopes | 6 | 2000 | 2571 | 0.040 |
Why?
|
Fibrinolysis | 1 | 1978 | 322 | 0.040 |
Why?
|
Thymoma | 1 | 1978 | 186 | 0.040 |
Why?
|
Reference Values | 2 | 1997 | 4982 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2005 | 3511 | 0.040 |
Why?
|
Central Nervous System | 1 | 2004 | 1357 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3921 | 0.030 |
Why?
|
Electric Conductivity | 1 | 1997 | 411 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13285 | 0.030 |
Why?
|
Caspases | 3 | 2005 | 928 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 4 | 1989 | 2556 | 0.030 |
Why?
|
Methotrexate | 2 | 1997 | 1728 | 0.030 |
Why?
|
Oncogene Proteins, Viral | 1 | 1997 | 362 | 0.030 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 1998 | 371 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2015 | 4208 | 0.030 |
Why?
|
Eye Diseases | 1 | 1981 | 669 | 0.030 |
Why?
|
Neutropenia | 3 | 1990 | 895 | 0.030 |
Why?
|
Transforming Growth Factor beta | 2 | 1995 | 2007 | 0.030 |
Why?
|
Mammals | 1 | 2001 | 1143 | 0.030 |
Why?
|
Administration, Oral | 1 | 2003 | 3914 | 0.030 |
Why?
|
TYK2 Kinase | 1 | 1995 | 38 | 0.030 |
Why?
|
Bone Marrow Examination | 2 | 1988 | 157 | 0.030 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 1996 | 230 | 0.030 |
Why?
|
Protamine Kinase | 1 | 1995 | 12 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 1996 | 318 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2013 | 19905 | 0.030 |
Why?
|
Databases, Factual | 1 | 2010 | 7730 | 0.030 |
Why?
|
Janus Kinase 1 | 1 | 1995 | 104 | 0.030 |
Why?
|
Zebrafish | 1 | 2007 | 2996 | 0.030 |
Why?
|
Immunologic Techniques | 2 | 1992 | 219 | 0.030 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 1995 | 146 | 0.030 |
Why?
|
Lung Neoplasms | 5 | 2003 | 13104 | 0.030 |
Why?
|
Chromosome Disorders | 3 | 1995 | 514 | 0.030 |
Why?
|
Endotoxins | 2 | 1988 | 527 | 0.030 |
Why?
|
Immunocompetence | 1 | 1995 | 136 | 0.030 |
Why?
|
Ricin | 2 | 1992 | 72 | 0.030 |
Why?
|
Baculoviridae | 1 | 1995 | 118 | 0.030 |
Why?
|
Ouabain | 2 | 1988 | 264 | 0.030 |
Why?
|
DNA | 7 | 1990 | 7294 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 1998 | 366 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fes | 1 | 1994 | 6 | 0.030 |
Why?
|
Chromatography, Affinity | 2 | 1994 | 549 | 0.030 |
Why?
|
DNA Nucleotidylexotransferase | 2 | 1985 | 64 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 1994 | 71 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 1991 | 2274 | 0.030 |
Why?
|
Receptors, Leukocyte-Adhesion | 2 | 1991 | 53 | 0.030 |
Why?
|
Spinal Cord | 1 | 2002 | 1810 | 0.030 |
Why?
|
Clonal Anergy | 1 | 1994 | 169 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 1996 | 535 | 0.030 |
Why?
|
Rats | 6 | 2003 | 24252 | 0.030 |
Why?
|
Genetic Vectors | 3 | 2003 | 3424 | 0.030 |
Why?
|
Dinoprostone | 1 | 1996 | 601 | 0.030 |
Why?
|
Cell Transformation, Viral | 3 | 1980 | 567 | 0.030 |
Why?
|
Dog Diseases | 1 | 1994 | 138 | 0.030 |
Why?
|
Blood Transfusion, Autologous | 1 | 1994 | 134 | 0.030 |
Why?
|
Mitosis | 2 | 2005 | 1208 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 755 | 0.030 |
Why?
|
Gene Rearrangement | 3 | 2003 | 1179 | 0.030 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2001 | 990 | 0.030 |
Why?
|
Busulfan | 2 | 1986 | 263 | 0.030 |
Why?
|
Drosophila | 1 | 2000 | 1491 | 0.030 |
Why?
|
Drug Administration Schedule | 3 | 1991 | 4933 | 0.030 |
Why?
|
History, 20th Century | 1 | 2001 | 2740 | 0.030 |
Why?
|
Interferon-alpha | 1 | 1997 | 895 | 0.030 |
Why?
|
Glycolysis | 2 | 2015 | 829 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 1997 | 871 | 0.030 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2013 | 129 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2021 | 9735 | 0.030 |
Why?
|
Actins | 2 | 1997 | 2121 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4805 | 0.030 |
Why?
|
Deferoxamine | 1 | 1993 | 151 | 0.030 |
Why?
|
GTPase-Activating Proteins | 2 | 1995 | 498 | 0.030 |
Why?
|
Receptors, Transferrin | 3 | 1992 | 296 | 0.030 |
Why?
|
Neurodegenerative Diseases | 1 | 2001 | 1061 | 0.030 |
Why?
|
Transduction, Genetic | 2 | 2008 | 913 | 0.030 |
Why?
|
Ubiquitin | 1 | 2017 | 851 | 0.030 |
Why?
|
Melphalan | 1 | 1994 | 431 | 0.030 |
Why?
|
Radioligand Assay | 1 | 1992 | 374 | 0.030 |
Why?
|
Remission Induction | 4 | 2003 | 2386 | 0.030 |
Why?
|
Research | 1 | 2001 | 1999 | 0.030 |
Why?
|
Graft Rejection | 2 | 1996 | 4397 | 0.030 |
Why?
|
Centrifugation, Density Gradient | 1 | 1992 | 313 | 0.030 |
Why?
|
Complement System Proteins | 4 | 1992 | 795 | 0.030 |
Why?
|
Isoantigens | 1 | 1994 | 567 | 0.030 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1992 | 212 | 0.030 |
Why?
|
Caspase 3 | 2 | 2005 | 758 | 0.030 |
Why?
|
Potassium | 5 | 1989 | 1336 | 0.030 |
Why?
|
Erythropoiesis | 2 | 1987 | 706 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 1993 | 489 | 0.030 |
Why?
|
Mannosephosphates | 1 | 1991 | 11 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 3 | 1991 | 675 | 0.020 |
Why?
|
Autonomic Nervous System | 1 | 1996 | 671 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2428 | 0.020 |
Why?
|
Antigen-Presenting Cells | 3 | 1990 | 973 | 0.020 |
Why?
|
Antioxidants | 1 | 1999 | 1659 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2000 | 1888 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 1 | 2011 | 193 | 0.020 |
Why?
|
Mannans | 1 | 1991 | 63 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1991 | 803 | 0.020 |
Why?
|
Sulfur Radioisotopes | 1 | 1990 | 116 | 0.020 |
Why?
|
Transplantation, Autologous | 3 | 1994 | 2124 | 0.020 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 1991 | 293 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 2 | 1995 | 403 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 1990 | 78 | 0.020 |
Why?
|
RNA Probes | 1 | 1990 | 113 | 0.020 |
Why?
|
Phosphoserine | 1 | 1991 | 206 | 0.020 |
Why?
|
Iodine Radioisotopes | 2 | 1991 | 1032 | 0.020 |
Why?
|
Methods | 2 | 1988 | 1129 | 0.020 |
Why?
|
Cross-Linking Reagents | 2 | 1991 | 694 | 0.020 |
Why?
|
Substance P | 1 | 1991 | 335 | 0.020 |
Why?
|
Molecular Weight | 4 | 1982 | 2255 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2013 | 11126 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 13882 | 0.020 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 1989 | 39 | 0.020 |
Why?
|
Cytosol | 3 | 1988 | 901 | 0.020 |
Why?
|
Immunophenotyping | 3 | 2003 | 1880 | 0.020 |
Why?
|
NADP | 1 | 2010 | 226 | 0.020 |
Why?
|
Receptors, Complement | 2 | 1989 | 264 | 0.020 |
Why?
|
Phytohemagglutinins | 2 | 1986 | 170 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2010 | 300 | 0.020 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 1989 | 87 | 0.020 |
Why?
|
Action Potentials | 1 | 1997 | 1806 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 1997 | 1741 | 0.020 |
Why?
|
Peritoneal Cavity | 1 | 1989 | 148 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2002 | 5096 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 21833 | 0.020 |
Why?
|
Neomycin | 1 | 1989 | 88 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3590 | 0.020 |
Why?
|
Peroxidase | 2 | 1989 | 611 | 0.020 |
Why?
|
Antibodies | 2 | 1994 | 2460 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2004 | 460 | 0.020 |
Why?
|
Glucose | 2 | 2011 | 4398 | 0.020 |
Why?
|
Amsacrine | 2 | 1985 | 18 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1990 | 798 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 15520 | 0.020 |
Why?
|
Microinjections | 3 | 1998 | 327 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 1972 | 934 | 0.020 |
Why?
|
Muscle Contraction | 2 | 1972 | 1235 | 0.020 |
Why?
|
Autophagy | 1 | 2016 | 1297 | 0.020 |
Why?
|
Infusions, Parenteral | 2 | 1985 | 419 | 0.020 |
Why?
|
Leukopenia | 1 | 1988 | 213 | 0.020 |
Why?
|
Erythrocyte Count | 1 | 1988 | 163 | 0.020 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 2007 | 58 | 0.020 |
Why?
|
Erythrocytes | 4 | 1989 | 2455 | 0.020 |
Why?
|
Arabinofuranosylcytosine Triphosphate | 1 | 1987 | 7 | 0.020 |
Why?
|
Arabinofuranosyluracil | 1 | 1987 | 10 | 0.020 |
Why?
|
Lactones | 1 | 1990 | 329 | 0.020 |
Why?
|
Chemotactic Factors | 1 | 1988 | 199 | 0.020 |
Why?
|
Cohort Studies | 1 | 2010 | 40558 | 0.020 |
Why?
|
Thromboplastin | 1 | 1989 | 291 | 0.020 |
Why?
|
Replicon | 1 | 1987 | 34 | 0.020 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2008 | 60 | 0.020 |
Why?
|
Collodion | 1 | 1987 | 34 | 0.020 |
Why?
|
Macrophage Activation | 2 | 1988 | 560 | 0.020 |
Why?
|
DNA, Single-Stranded | 1 | 2009 | 355 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 906 | 0.020 |
Why?
|
Blood Coagulation Factors | 1 | 1989 | 355 | 0.020 |
Why?
|
Immunoglobulin G | 3 | 2000 | 4561 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 1991 | 822 | 0.020 |
Why?
|
Immunoconjugates | 1 | 1994 | 901 | 0.020 |
Why?
|
Virulence Factors, Bordetella | 1 | 1987 | 156 | 0.020 |
Why?
|
Pertussis Toxin | 1 | 1987 | 178 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 1 | 1996 | 1271 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2504 | 0.020 |
Why?
|
Cell Count | 3 | 1987 | 1856 | 0.020 |
Why?
|
Sarcoma | 2 | 1989 | 1897 | 0.020 |
Why?
|
Sodium | 3 | 1987 | 1622 | 0.020 |
Why?
|
Aminoquinolines | 1 | 1987 | 109 | 0.020 |
Why?
|
Anemia, Refractory | 1 | 1986 | 17 | 0.020 |
Why?
|
Carbocyanines | 1 | 1987 | 174 | 0.020 |
Why?
|
Young Adult | 1 | 2013 | 56434 | 0.020 |
Why?
|
Purines | 1 | 2010 | 594 | 0.020 |
Why?
|
Thanatophoric Dysplasia | 1 | 2005 | 5 | 0.020 |
Why?
|
Callitrichinae | 1 | 1985 | 23 | 0.020 |
Why?
|
Nitriles | 1 | 2011 | 955 | 0.020 |
Why?
|
Cell Death | 1 | 1992 | 1707 | 0.020 |
Why?
|
Immunohistochemistry | 4 | 2002 | 11366 | 0.020 |
Why?
|
Saguinus | 1 | 1985 | 17 | 0.020 |
Why?
|
Suspensions | 1 | 1986 | 65 | 0.020 |
Why?
|
Pregnancy | 2 | 2007 | 29144 | 0.020 |
Why?
|
Eflornithine | 1 | 1985 | 31 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1798 | 0.020 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 4 | 1991 | 906 | 0.020 |
Why?
|
Ornithine | 1 | 1985 | 78 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2010 | 970 | 0.020 |
Why?
|
Agar | 1 | 1985 | 56 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 944 | 0.020 |
Why?
|
Receptors, Fc | 1 | 1989 | 541 | 0.020 |
Why?
|
Polyglutamic Acid | 1 | 1985 | 44 | 0.020 |
Why?
|
Adolescent | 11 | 2006 | 85784 | 0.020 |
Why?
|
Tritium | 1 | 1985 | 745 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1375 | 0.020 |
Why?
|
Phloretin | 1 | 2004 | 17 | 0.020 |
Why?
|
Cell Aggregation | 1 | 1985 | 244 | 0.020 |
Why?
|
Endocytosis | 1 | 1990 | 985 | 0.020 |
Why?
|
Cricetinae | 2 | 2002 | 2475 | 0.020 |
Why?
|
Phagocytes | 1 | 1986 | 297 | 0.020 |
Why?
|
Treatment Failure | 1 | 2011 | 2618 | 0.020 |
Why?
|
Splenectomy | 1 | 1986 | 395 | 0.020 |
Why?
|
Chromosomes, Human, 16-18 | 1 | 1984 | 32 | 0.020 |
Why?
|
Epithelium | 1 | 1989 | 1679 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2007 | 1247 | 0.020 |
Why?
|
Transformation, Genetic | 1 | 2004 | 192 | 0.020 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2005 | 97 | 0.020 |
Why?
|
Oxidation-Reduction | 2 | 2006 | 2184 | 0.020 |
Why?
|
Chromosomes, Human, 1-3 | 1 | 1983 | 23 | 0.010 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2004 | 197 | 0.010 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 1983 | 80 | 0.010 |
Why?
|
Anemia, Aplastic | 1 | 1986 | 226 | 0.010 |
Why?
|
Deoxyglucose | 1 | 2004 | 337 | 0.010 |
Why?
|
ras Proteins | 1 | 2009 | 1060 | 0.010 |
Why?
|
Cytogenetics | 2 | 1995 | 203 | 0.010 |
Why?
|
Mesonephroma | 1 | 1983 | 18 | 0.010 |
Why?
|
Plasmacytoma | 1 | 2004 | 183 | 0.010 |
Why?
|
Chromosomes, Human, 21-22 and Y | 1 | 1983 | 46 | 0.010 |
Why?
|
Dysgerminoma | 1 | 1983 | 66 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1991 | 3873 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3064 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2000 | 5223 | 0.010 |
Why?
|
Biological Assay | 1 | 1987 | 652 | 0.010 |
Why?
|
Drug Resistance, Multiple | 1 | 2004 | 252 | 0.010 |
Why?
|
Muscular Dystrophies | 1 | 2006 | 393 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1984 | 668 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2007 | 1865 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 1989 | 1000 | 0.010 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2004 | 250 | 0.010 |
Why?
|
Collagen | 1 | 1992 | 2688 | 0.010 |
Why?
|
Antigens, Viral, Tumor | 2 | 1982 | 156 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1996 | 494 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2015 | 21747 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1996 | 4386 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2004 | 743 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1990 | 1782 | 0.010 |
Why?
|
Annexin A5 | 1 | 2003 | 103 | 0.010 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2004 | 440 | 0.010 |
Why?
|
HeLa Cells | 2 | 2001 | 3130 | 0.010 |
Why?
|
Choriocarcinoma | 1 | 1983 | 126 | 0.010 |
Why?
|
Tachycardia | 1 | 1985 | 619 | 0.010 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 3 | 1991 | 318 | 0.010 |
Why?
|
Interferon Type I | 1 | 1986 | 542 | 0.010 |
Why?
|
Goats | 1 | 1982 | 171 | 0.010 |
Why?
|
Armadillo Domain Proteins | 1 | 2002 | 22 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2004 | 583 | 0.010 |
Why?
|
Catenins | 1 | 2002 | 41 | 0.010 |
Why?
|
Mitobronitol | 1 | 1981 | 3 | 0.010 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2003 | 154 | 0.010 |
Why?
|
Mouth Mucosa | 1 | 2005 | 434 | 0.010 |
Why?
|
Child, Preschool | 4 | 2003 | 41005 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2002 | 118 | 0.010 |
Why?
|
Integrin alpha4 | 1 | 2002 | 92 | 0.010 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2003 | 374 | 0.010 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 112 | 0.010 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2002 | 63 | 0.010 |
Why?
|
Vinca Alkaloids | 1 | 1981 | 35 | 0.010 |
Why?
|
Syndrome | 2 | 1985 | 3252 | 0.010 |
Why?
|
Palatine Tonsil | 2 | 1997 | 193 | 0.010 |
Why?
|
PC12 Cells | 1 | 2002 | 331 | 0.010 |
Why?
|
Caspase 9 | 1 | 2002 | 188 | 0.010 |
Why?
|
Graft vs Host Reaction | 1 | 1981 | 104 | 0.010 |
Why?
|
Guanosine Triphosphate | 1 | 2002 | 321 | 0.010 |
Why?
|
Receptors, Growth Factor | 1 | 2002 | 334 | 0.010 |
Why?
|
Lymphoma, T-Cell | 1 | 2004 | 299 | 0.010 |
Why?
|
Helminth Proteins | 1 | 2002 | 171 | 0.010 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2003 | 440 | 0.010 |
Why?
|
Estrogen Antagonists | 1 | 1981 | 152 | 0.010 |
Why?
|
Cells, Immobilized | 1 | 2000 | 36 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2002 | 772 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2001 | 547 | 0.010 |
Why?
|
Nucleic Acid Conformation | 1 | 2004 | 913 | 0.010 |
Why?
|
Vincristine | 1 | 1983 | 1039 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2003 | 563 | 0.010 |
Why?
|
Fetus | 3 | 2002 | 1880 | 0.010 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2000 | 5 | 0.010 |
Why?
|
Teratoma | 1 | 1983 | 395 | 0.010 |
Why?
|
Homozygote | 1 | 2005 | 1787 | 0.010 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2003 | 294 | 0.010 |
Why?
|
Serpins | 1 | 2002 | 247 | 0.010 |
Why?
|
Spleen | 2 | 2003 | 2362 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 5986 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2003 | 880 | 0.010 |
Why?
|
Aphidicolin | 2 | 1992 | 36 | 0.010 |
Why?
|
Chick Embryo | 2 | 2000 | 982 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2003 | 853 | 0.010 |
Why?
|
Serine | 1 | 2003 | 826 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 686 | 0.010 |
Why?
|
Sheep | 1 | 1982 | 1437 | 0.010 |
Why?
|
Microscopy, Electron | 2 | 1985 | 2646 | 0.010 |
Why?
|
Immunotherapy | 1 | 1995 | 4445 | 0.010 |
Why?
|
Platelet Count | 2 | 1995 | 780 | 0.010 |
Why?
|
Dimethyl Sulfoxide | 1 | 2000 | 249 | 0.010 |
Why?
|
Fibroblasts | 1 | 2010 | 4162 | 0.010 |
Why?
|
Infant | 3 | 1994 | 35134 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2002 | 552 | 0.010 |
Why?
|
Child | 5 | 2009 | 77708 | 0.010 |
Why?
|
Presenilin-1 | 1 | 2003 | 635 | 0.010 |
Why?
|
CHO Cells | 1 | 2002 | 1409 | 0.010 |
Why?
|
Eosinophils | 1 | 1984 | 955 | 0.010 |
Why?
|
Trisomy | 2 | 1995 | 266 | 0.010 |
Why?
|
Hypotension | 1 | 1985 | 884 | 0.010 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 664 | 0.010 |
Why?
|
Solubility | 1 | 2000 | 1088 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 1987 | 1917 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1985 | 2373 | 0.010 |
Why?
|
Extracellular Space | 1 | 2000 | 595 | 0.010 |
Why?
|
Chromatography | 1 | 1978 | 206 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6194 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2003 | 1730 | 0.010 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2003 | 670 | 0.010 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2003 | 484 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2002 | 627 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 1998 | 191 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1985 | 1821 | 0.010 |
Why?
|
Immunoglobulin M | 2 | 1986 | 1537 | 0.010 |
Why?
|
Heterozygote | 1 | 2005 | 2804 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2009 | 3084 | 0.010 |
Why?
|
Prednisone | 1 | 1983 | 1574 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2003 | 847 | 0.010 |
Why?
|
SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 1997 | 45 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2007 | 1418 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 365 | 0.010 |
Why?
|
Ketorolac | 1 | 1998 | 79 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2000 | 595 | 0.010 |
Why?
|
Menorrhagia | 1 | 1978 | 63 | 0.010 |
Why?
|
Receptors, Formyl Peptide | 2 | 1988 | 145 | 0.010 |
Why?
|
Neurons | 1 | 1997 | 9340 | 0.010 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 1997 | 143 | 0.010 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2000 | 555 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2003 | 2088 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 1999 | 892 | 0.010 |
Why?
|
DNA Damage | 1 | 2007 | 2432 | 0.010 |
Why?
|
Prostaglandins | 1 | 1998 | 405 | 0.010 |
Why?
|
Biological Evolution | 1 | 1983 | 1077 | 0.010 |
Why?
|
Mediastinum | 1 | 1978 | 267 | 0.010 |
Why?
|
Receptors, Fibronectin | 1 | 1996 | 39 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2003 | 1335 | 0.010 |
Why?
|
Fluorouracil | 1 | 1981 | 1619 | 0.010 |
Why?
|
Myelodysplastic Syndromes | 1 | 1986 | 1352 | 0.010 |
Why?
|
Dogs | 2 | 1994 | 3912 | 0.010 |
Why?
|
Fungal Proteins | 1 | 2000 | 912 | 0.010 |
Why?
|
Hematuria | 1 | 1978 | 235 | 0.010 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1996 | 143 | 0.010 |
Why?
|
Integrin alpha4beta1 | 1 | 1996 | 121 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 1998 | 8300 | 0.010 |
Why?
|
Protein Phosphatase 2 | 1 | 1997 | 229 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2001 | 1970 | 0.010 |
Why?
|
HLA-DR7 Antigen | 1 | 1994 | 27 | 0.010 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 1987 | 349 | 0.010 |
Why?
|
Brain | 1 | 2002 | 26386 | 0.010 |
Why?
|
MAP Kinase Kinase 1 | 1 | 1996 | 337 | 0.010 |
Why?
|
Blood Coagulation Disorders | 1 | 1978 | 337 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1978 | 995 | 0.010 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1994 | 280 | 0.010 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1995 | 322 | 0.010 |
Why?
|
Estrogens | 1 | 1981 | 1566 | 0.010 |
Why?
|
Moths | 1 | 1994 | 87 | 0.010 |
Why?
|
Regeneration | 1 | 1983 | 1485 | 0.010 |
Why?
|
HLA Antigens | 3 | 1987 | 1382 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2003 | 2108 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 1996 | 707 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2003 | 1708 | 0.010 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 1995 | 462 | 0.010 |
Why?
|
United States | 1 | 2001 | 69869 | 0.010 |
Why?
|
Drug Antagonism | 1 | 1972 | 50 | 0.010 |
Why?
|
Periodicity | 1 | 1994 | 364 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 1983 | 2269 | 0.010 |
Why?
|
Models, Genetic | 1 | 2003 | 3493 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 1981 | 1856 | 0.010 |
Why?
|
Infusion Pumps | 1 | 1993 | 163 | 0.010 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1992 | 57 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1986 | 2988 | 0.010 |
Why?
|
Bradykinin | 1 | 1972 | 214 | 0.010 |
Why?
|
Atropine | 1 | 1972 | 244 | 0.010 |
Why?
|
Survival Analysis | 1 | 2005 | 10252 | 0.010 |
Why?
|
Histamine Antagonists | 1 | 1972 | 93 | 0.010 |
Why?
|
Thymidine Kinase | 1 | 1992 | 290 | 0.010 |
Why?
|
Xanthines | 1 | 1972 | 121 | 0.010 |
Why?
|
Cations, Divalent | 1 | 1992 | 166 | 0.010 |
Why?
|
Peptide Mapping | 1 | 1992 | 263 | 0.010 |
Why?
|
Cattle | 1 | 1997 | 3922 | 0.010 |
Why?
|
Genistein | 1 | 1991 | 88 | 0.010 |
Why?
|
Microbial Collagenase | 1 | 1992 | 122 | 0.010 |
Why?
|
DNA, Viral | 1 | 1978 | 2227 | 0.010 |
Why?
|
Digoxin | 1 | 1972 | 250 | 0.010 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1991 | 113 | 0.010 |
Why?
|
Bryostatins | 1 | 1990 | 24 | 0.010 |
Why?
|
Isoflavones | 1 | 1991 | 139 | 0.010 |
Why?
|
Edetic Acid | 1 | 1991 | 275 | 0.010 |
Why?
|
Histamine | 1 | 1972 | 507 | 0.010 |
Why?
|
Chromosome Inversion | 1 | 1991 | 127 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1972 | 1386 | 0.010 |
Why?
|
Acetylcholine | 1 | 1972 | 621 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 12952 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1991 | 2540 | 0.010 |
Why?
|
Ileum | 1 | 1972 | 565 | 0.010 |
Why?
|
Valinomycin | 1 | 1989 | 19 | 0.010 |
Why?
|
Naphthol AS D Esterase | 1 | 1989 | 14 | 0.010 |
Why?
|
Microspheres | 1 | 1992 | 777 | 0.010 |
Why?
|
Ionomycin | 1 | 1989 | 109 | 0.010 |
Why?
|
Kanamycin Kinase | 1 | 1989 | 34 | 0.010 |
Why?
|
Macrolides | 1 | 1990 | 201 | 0.010 |
Why?
|
Metaphase | 1 | 1989 | 151 | 0.010 |
Why?
|
Electrocardiography | 1 | 1983 | 6442 | 0.010 |
Why?
|
E-Selectin | 1 | 1991 | 579 | 0.010 |
Why?
|
Magnetics | 1 | 1992 | 606 | 0.010 |
Why?
|
Mitotic Index | 1 | 1989 | 172 | 0.010 |
Why?
|
Ethers | 1 | 1989 | 75 | 0.010 |
Why?
|
P-Selectin | 1 | 1991 | 601 | 0.010 |
Why?
|
Genetic Variation | 1 | 2004 | 6542 | 0.010 |
Why?
|
Prostatectomy | 1 | 1978 | 1890 | 0.010 |
Why?
|
Amiloride | 1 | 1988 | 121 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2000 | 2752 | 0.010 |
Why?
|
Polycarboxylate Cement | 1 | 1988 | 18 | 0.010 |
Why?
|
Propionates | 1 | 1989 | 169 | 0.010 |
Why?
|
Antigens, CD19 | 1 | 1991 | 380 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4464 | 0.010 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1991 | 659 | 0.000 |
Why?
|
Immune Sera | 1 | 1988 | 641 | 0.000 |
Why?
|
Phospholipases | 1 | 1987 | 72 | 0.000 |
Why?
|
Histocytochemistry | 1 | 1989 | 719 | 0.000 |
Why?
|
Serotonin | 1 | 1972 | 1017 | 0.000 |
Why?
|
Drug Interactions | 1 | 1972 | 1460 | 0.000 |
Why?
|
Filtration | 1 | 1988 | 234 | 0.000 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1989 | 1085 | 0.000 |
Why?
|
Hemorrhage | 1 | 1999 | 3461 | 0.000 |
Why?
|
Arachidonic Acids | 1 | 1987 | 299 | 0.000 |
Why?
|
Drug Contamination | 1 | 1988 | 147 | 0.000 |
Why?
|
Membrane Lipids | 1 | 1987 | 249 | 0.000 |
Why?
|
Receptors, Complement 3b | 1 | 1986 | 145 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 1988 | 11718 | 0.000 |
Why?
|
Chemistry, Physical | 1 | 1986 | 156 | 0.000 |
Why?
|
Arachidonic Acid | 1 | 1987 | 434 | 0.000 |
Why?
|
Chemical Phenomena | 1 | 1986 | 518 | 0.000 |
Why?
|
Immunoenzyme Techniques | 1 | 1989 | 1799 | 0.000 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1987 | 769 | 0.000 |
Why?
|
Haptens | 1 | 1985 | 166 | 0.000 |
Why?
|
Receptors, IgG | 1 | 1989 | 582 | 0.000 |
Why?
|
Cell-Free System | 1 | 1986 | 344 | 0.000 |
Why?
|
Neural Pathways | 1 | 1996 | 2973 | 0.000 |
Why?
|
Prospective Studies | 2 | 1987 | 53291 | 0.000 |
Why?
|
Intracellular Fluid | 1 | 1985 | 203 | 0.000 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1985 | 370 | 0.000 |
Why?
|
Staining and Labeling | 1 | 1989 | 1101 | 0.000 |
Why?
|
Diterpenes | 1 | 1985 | 173 | 0.000 |
Why?
|
Histocompatibility Antigens | 1 | 1985 | 471 | 0.000 |
Why?
|
Inosine | 1 | 1985 | 133 | 0.000 |
Why?
|
Chromosome Banding | 1 | 1984 | 278 | 0.000 |
Why?
|
Twins | 1 | 1985 | 339 | 0.000 |
Why?
|
Phospholipids | 1 | 1987 | 784 | 0.000 |
Why?
|
Hybridomas | 1 | 1985 | 452 | 0.000 |
Why?
|
Histocompatibility Testing | 1 | 1985 | 741 | 0.000 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1985 | 379 | 0.000 |
Why?
|
Antigen-Antibody Complex | 1 | 1985 | 517 | 0.000 |
Why?
|
Interleukin-4 | 1 | 1987 | 1147 | 0.000 |
Why?
|
beta 2-Microglobulin | 1 | 1983 | 315 | 0.000 |
Why?
|
Brain Mapping | 1 | 1998 | 6670 | 0.000 |
Why?
|
Peptide Hydrolases | 1 | 1985 | 634 | 0.000 |
Why?
|
Body Temperature | 1 | 1985 | 777 | 0.000 |
Why?
|
Herpesvirus 4, Human | 1 | 1987 | 1041 | 0.000 |
Why?
|
Coronary Circulation | 1 | 1988 | 1572 | 0.000 |
Why?
|
Gold | 1 | 1985 | 484 | 0.000 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1983 | 482 | 0.000 |
Why?
|
Cytoplasmic Granules | 1 | 1984 | 610 | 0.000 |
Why?
|
Evaluation Studies as Topic | 1 | 1983 | 1681 | 0.000 |
Why?
|
Phagocytosis | 1 | 1986 | 1539 | 0.000 |
Why?
|
Thymus Gland | 1 | 1985 | 1267 | 0.000 |
Why?
|
Genes, Viral | 1 | 1980 | 718 | 0.000 |
Why?
|
Hemoglobins | 1 | 1985 | 1532 | 0.000 |
Why?
|
Hemodynamics | 1 | 1988 | 4196 | 0.000 |
Why?
|
Mitochondria | 1 | 1988 | 3514 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1992 | 9240 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1985 | 3475 | 0.000 |
Why?
|
Virus Replication | 1 | 1982 | 2535 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1995 | 39052 | 0.000 |
Why?
|
Coronary Disease | 1 | 1988 | 6077 | 0.000 |
Why?
|
Aminophylline | 1 | 1972 | 40 | 0.000 |
Why?
|
Microscopy, Phase-Contrast | 1 | 1972 | 115 | 0.000 |
Why?
|
Theophylline | 1 | 1972 | 132 | 0.000 |
Why?
|
Skin | 1 | 1985 | 4371 | 0.000 |
Why?
|
Culture Techniques | 1 | 1972 | 554 | 0.000 |
Why?
|